Trial Projects

What is a Trial Project?
1 Trial Project found

Transatlantic, multi-center, placebo-controlled, randomized, double-blind clinical trial to demonstrate that transdermal nicotine treatment retards parkinson's disease progression as measured by change in total (part I, II, III) UPDRS score between baseline and after 52 weeks of study treatment plus two more months wash out (60 weeks).

Sponsor: Philipps-University Marburg

Public web page: Not specified

Start date: 17th Oct 2012

End date: 15th Sep 2016

Powered by
(v.1.17.3)

(LDH: v0.3.4)

Copyright © 2008 - 2023 The University of Manchester and HITS gGmbH